Frazier Healthcare Partners, a Seattle, Wash., and Menlo Park, Calif.-based provider of growth capital to healthcare companies, announced that Hendrik Struik has re-joined the firm as an Operating Partner on the Growth Buyout team.
Struik will assist the Growth Buyout team with identifying and executing opportunities in the differentiated medical products and supplies space.
The former Chief Executive Officer of Laboratory Supply Company, a Frazier portfolio company, he rejoined Frazier following the sale of LABSCO to McKesson Corporation in May of 2016.
Mr. Struik originally joined Frazier Healthcare in July 2012 as an Operating Partner, working with the firm’s Growth Buyout team to identify opportunities in differentiated medical products, supplies and devices and outsourced technology-enabled services.
From 2009 to 2012, he served as the Chief Executive Officer and President of Sarnova, a provider of healthcare products to the emergency medical and acute care services markets.
Prior to Sarnova, Mr. Struik spent over 20 years with Cardinal Health and predecessor companies including Baxter and Allegiance Healthcare.
Founded in 1991, Frazier Healthcare Partners is a provider of growth and venture capital to emerging healthcare service and biopharma companies. With nearly $2.9 billion under management, the firm has invested in over 170 companies ranging from early-stage venture investments to buyouts of profitable lower-middle market companies.